Blog - Patient Focused Medicines Development
FDA calls on industry to speed up trials process

The FDA appears to be taking its regulatory role to new levels as it seeks to shape a better medicines development ecosystem. The recent statement by FDA Commissioner Dr Scott Gottlieb focused on new strategies to modernise clinical trials to advance precision medicine, patient protections and more efficient product development. PFMD welcomes this strong stance from the Administration, as the...

Read More